BIO-UV Group S.A.
EPA:ALTUV.PA
1.8 (EUR) • At close November 12, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
---|---|---|---|---|---|---|---|---|
Revenue
| 43.1 | 51.286 | 33.462 | 32.175 | 19.978 | 12.415 | 10.181 | 9.624 |
Cost of Revenue
| 17.559 | 46.58 | 31.623 | 30.392 | 13.546 | 7.782 | 5.721 | 6.074 |
Gross Profit
| 25.541 | 4.707 | 1.839 | 1.783 | 6.432 | 4.633 | 4.46 | 3.55 |
Gross Profit Ratio
| 0.593 | 0.092 | 0.055 | 0.055 | 0.322 | 0.373 | 0.438 | 0.369 |
Reseach & Development Expenses
| 2.893 | 0.002 | 0.002 | 0.001 | 0.001 | 0.001 | 0 | 0 |
General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 0.477 | 0.485 | 0.596 | 0.148 | 0.049 | 0.004 | 0.003 | 0.003 |
Other Expenses
| -40.8 | -0.168 | -0.303 | -0.306 | 6.739 | 4.618 | 0 | 3.888 |
Operating Expenses
| 23.263 | 0.653 | 0.899 | 0.454 | 6.739 | 4.618 | 4.05 | 3.888 |
Operating Income
| 2.3 | 4.054 | 0.94 | 1.329 | -0.307 | 0.015 | 0.406 | -0.343 |
Operating Income Ratio
| 0.053 | 0.079 | 0.028 | 0.041 | -0.015 | 0.001 | 0.04 | -0.036 |
Total Other Income Expenses Net
| -2.3 | -1.059 | -0.309 | -0.775 | -0.262 | -0.316 | -0.788 | -0.777 |
Income Before Tax
| 0.974 | 2.995 | 0.631 | 0.554 | -0.569 | -0.265 | -0.382 | -0.816 |
Income Before Tax Ratio
| 0.023 | 0.058 | 0.019 | 0.017 | -0.028 | -0.021 | -0.038 | -0.085 |
Income Tax Expense
| -0.109 | 0.577 | -0.058 | -0.03 | -0.329 | -0.243 | -0.335 | -0.043 |
Net Income
| 0.125 | 2.418 | 0.689 | 0.584 | -0.24 | 0.046 | -0.091 | 1.277 |
Net Income Ratio
| 0.003 | 0.047 | 0.021 | 0.018 | -0.012 | 0.004 | -0.009 | 0.133 |
EPS
| 0.01 | 0.24 | 0.068 | 0.068 | -0.031 | 0.006 | -0.012 | 0.16 |
EPS Diluted
| 0.01 | 0.23 | 0.066 | 0.066 | -0.031 | 0.006 | -0.012 | 0.16 |
EBITDA
| 5.5 | 6.759 | 3.293 | 3.12 | 1.347 | 0.908 | 1.074 | 0.96 |
EBITDA Ratio
| 0.128 | 0.132 | 0.098 | 0.097 | 0.067 | 0.073 | 0.105 | 0.1 |